Benzinga | Nov 1, 2021 08:40AM EDT

Argus Research Upgrades Merck & Co to Buy, Announces $110 Price Target

Argus Research analyst David Toung upgrades Merck & Co (NYSE:MRK) from Hold to Buy and announces $110 price target.